Go Pro

National Research (NRC) Competitors

National Research logo
$20.14 +0.63 (+3.23%)
As of 11:58 AM Eastern
This is a fair market value price provided by Massive. Learn more.

NRC vs. STGW, EVTC, PRG, NEO, and DXC

Should you buy National Research stock or one of its competitors? MarketBeat compares National Research with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with National Research include Stagwell (STGW), Evertec (EVTC), PROG (PRG), NeoGenomics (NEO), and DXC Technology (DXC).

How does National Research compare to Stagwell?

National Research (NASDAQ:NRC) and Stagwell (NASDAQ:STGW) are related companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.

National Research currently has a consensus price target of $26.00, suggesting a potential upside of 29.10%. Stagwell has a consensus price target of $9.40, suggesting a potential upside of 8.00%. Given National Research's higher probable upside, analysts clearly believe National Research is more favorable than Stagwell.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Research
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Stagwell
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57

47.3% of National Research shares are held by institutional investors. Comparatively, 35.6% of Stagwell shares are held by institutional investors. 9.2% of National Research shares are held by insiders. Comparatively, 11.2% of Stagwell shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

National Research has a beta of 0.35, suggesting that its share price is 65% less volatile than the broader market. Comparatively, Stagwell has a beta of 1.25, suggesting that its share price is 25% more volatile than the broader market.

National Research has a net margin of 4.18% compared to Stagwell's net margin of 0.53%. National Research's return on equity of 142.50% beat Stagwell's return on equity.

Company Net Margins Return on Equity Return on Assets
National Research4.18% 142.50% 14.70%
Stagwell 0.53%26.66%4.76%

In the previous week, Stagwell had 5 more articles in the media than National Research. MarketBeat recorded 18 mentions for Stagwell and 13 mentions for National Research. National Research's average media sentiment score of 0.77 beat Stagwell's score of 0.71 indicating that National Research is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Research
3 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Stagwell
4 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Stagwell has higher revenue and earnings than National Research. National Research is trading at a lower price-to-earnings ratio than Stagwell, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Research$140.00M3.27$11.60M$0.2580.56
Stagwell$2.91B0.74$29.10M$0.06145.07

Summary

National Research and Stagwell tied by winning 8 of the 16 factors compared between the two stocks.

How does National Research compare to Evertec?

Evertec (NYSE:EVTC) and National Research (NASDAQ:NRC) are related small-cap companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation and risk.

Evertec has a beta of 0.7, meaning that its share price is 30% less volatile than the broader market. Comparatively, National Research has a beta of 0.35, meaning that its share price is 65% less volatile than the broader market.

In the previous week, National Research had 9 more articles in the media than Evertec. MarketBeat recorded 13 mentions for National Research and 4 mentions for Evertec. National Research's average media sentiment score of 0.77 beat Evertec's score of 0.60 indicating that National Research is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Evertec
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
National Research
3 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Evertec has a net margin of 13.95% compared to National Research's net margin of 4.18%. National Research's return on equity of 142.50% beat Evertec's return on equity.

Company Net Margins Return on Equity Return on Assets
Evertec13.95% 31.40% 9.36%
National Research 4.18%142.50%14.70%

Evertec presently has a consensus target price of $32.75, indicating a potential upside of 5.00%. National Research has a consensus target price of $26.00, indicating a potential upside of 29.10%. Given National Research's stronger consensus rating and higher probable upside, analysts plainly believe National Research is more favorable than Evertec.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Evertec
0 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
National Research
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

96.8% of Evertec shares are owned by institutional investors. Comparatively, 47.3% of National Research shares are owned by institutional investors. 1.1% of Evertec shares are owned by company insiders. Comparatively, 9.2% of National Research shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Evertec pays an annual dividend of $0.20 per share and has a dividend yield of 0.6%. National Research pays an annual dividend of $0.64 per share and has a dividend yield of 3.2%. Evertec pays out 9.7% of its earnings in the form of a dividend. National Research pays out 256.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Evertec has higher revenue and earnings than National Research. Evertec is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Evertec$931.82M2.06$141.59M$2.0715.07
National Research$140.00M3.27$11.60M$0.2580.56

Summary

National Research beats Evertec on 10 of the 18 factors compared between the two stocks.

How does National Research compare to PROG?

National Research (NASDAQ:NRC) and PROG (NYSE:PRG) are related small-cap companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, analyst recommendations and profitability.

National Research pays an annual dividend of $0.64 per share and has a dividend yield of 3.2%. PROG pays an annual dividend of $0.56 per share and has a dividend yield of 1.2%. National Research pays out 256.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. PROG pays out 15.5% of its earnings in the form of a dividend. PROG has increased its dividend for 2 consecutive years.

National Research presently has a consensus target price of $26.00, indicating a potential upside of 29.10%. PROG has a consensus target price of $49.44, indicating a potential upside of 9.21%. Given National Research's higher probable upside, equities analysts clearly believe National Research is more favorable than PROG.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Research
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
PROG
0 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.80

In the previous week, PROG had 20 more articles in the media than National Research. MarketBeat recorded 33 mentions for PROG and 13 mentions for National Research. National Research's average media sentiment score of 0.77 beat PROG's score of 0.73 indicating that National Research is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Research
3 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PROG
8 Very Positive mention(s)
6 Positive mention(s)
11 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

PROG has a net margin of 5.57% compared to National Research's net margin of 4.18%. National Research's return on equity of 142.50% beat PROG's return on equity.

Company Net Margins Return on Equity Return on Assets
National Research4.18% 142.50% 14.70%
PROG 5.57%21.88%9.15%

PROG has higher revenue and earnings than National Research. PROG is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Research$140.00M3.27$11.60M$0.2580.56
PROG$2.61B0.69$146.79M$3.6212.51

47.3% of National Research shares are owned by institutional investors. Comparatively, 97.9% of PROG shares are owned by institutional investors. 9.2% of National Research shares are owned by company insiders. Comparatively, 3.7% of PROG shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

National Research has a beta of 0.35, indicating that its stock price is 65% less volatile than the broader market. Comparatively, PROG has a beta of 1.78, indicating that its stock price is 78% more volatile than the broader market.

Summary

PROG beats National Research on 12 of the 20 factors compared between the two stocks.

How does National Research compare to NeoGenomics?

National Research (NASDAQ:NRC) and NeoGenomics (NASDAQ:NEO) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

National Research has higher earnings, but lower revenue than NeoGenomics. NeoGenomics is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Research$140.00M3.27$11.60M$0.2580.56
NeoGenomics$727.33M2.87-$108.03M-$0.40N/A

National Research currently has a consensus price target of $26.00, suggesting a potential upside of 29.10%. NeoGenomics has a consensus price target of $16.71, suggesting a potential upside of 2.92%. Given National Research's higher probable upside, research analysts plainly believe National Research is more favorable than NeoGenomics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Research
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
NeoGenomics
1 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.55

47.3% of National Research shares are held by institutional investors. Comparatively, 98.5% of NeoGenomics shares are held by institutional investors. 9.2% of National Research shares are held by insiders. Comparatively, 1.1% of NeoGenomics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, NeoGenomics had 15 more articles in the media than National Research. MarketBeat recorded 28 mentions for NeoGenomics and 13 mentions for National Research. National Research's average media sentiment score of 0.77 beat NeoGenomics' score of 0.53 indicating that National Research is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Research
3 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
NeoGenomics
7 Very Positive mention(s)
3 Positive mention(s)
14 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

National Research has a net margin of 4.18% compared to NeoGenomics' net margin of -6.77%. National Research's return on equity of 142.50% beat NeoGenomics' return on equity.

Company Net Margins Return on Equity Return on Assets
National Research4.18% 142.50% 14.70%
NeoGenomics -6.77%-1.99%-1.21%

National Research has a beta of 0.35, meaning that its share price is 65% less volatile than the broader market. Comparatively, NeoGenomics has a beta of 1.74, meaning that its share price is 74% more volatile than the broader market.

Summary

National Research beats NeoGenomics on 10 of the 16 factors compared between the two stocks.

How does National Research compare to DXC Technology?

DXC Technology (NYSE:DXC) and National Research (NASDAQ:NRC) are related small-cap companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, media sentiment, analyst recommendations, dividends and earnings.

DXC Technology has higher revenue and earnings than National Research. DXC Technology is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DXC Technology$12.64B0.14$18M$0.7015.96
National Research$140.00M3.27$11.60M$0.2580.56

DXC Technology has a beta of 0.79, indicating that its share price is 21% less volatile than the broader market. Comparatively, National Research has a beta of 0.35, indicating that its share price is 65% less volatile than the broader market.

96.2% of DXC Technology shares are held by institutional investors. Comparatively, 47.3% of National Research shares are held by institutional investors. 1.1% of DXC Technology shares are held by insiders. Comparatively, 9.2% of National Research shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, DXC Technology had 15 more articles in the media than National Research. MarketBeat recorded 28 mentions for DXC Technology and 13 mentions for National Research. National Research's average media sentiment score of 0.77 beat DXC Technology's score of 0.18 indicating that National Research is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DXC Technology
8 Very Positive mention(s)
1 Positive mention(s)
15 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
National Research
3 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

National Research has a net margin of 4.18% compared to DXC Technology's net margin of 0.99%. National Research's return on equity of 142.50% beat DXC Technology's return on equity.

Company Net Margins Return on Equity Return on Assets
DXC Technology0.99% 15.60% 3.94%
National Research 4.18%142.50%14.70%

DXC Technology currently has a consensus target price of $11.81, indicating a potential upside of 5.76%. National Research has a consensus target price of $26.00, indicating a potential upside of 29.10%. Given National Research's stronger consensus rating and higher possible upside, analysts plainly believe National Research is more favorable than DXC Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DXC Technology
3 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.70
National Research
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

National Research beats DXC Technology on 10 of the 16 factors compared between the two stocks.

Get National Research News Delivered to You Automatically

Sign up to receive the latest news and ratings for NRC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NRC vs. The Competition

MetricNational ResearchHealthcare Technology IndustryHealthcare SectorNASDAQ Exchange
Market Cap$458.06M$1.37B$6.79B$12.63B
Dividend Yield3.38%4.76%2.59%10.03%
P/E Ratio80.55275.64282.1425.05
Price / Sales3.2759.74573.4380.07
Price / Cash15.5230.5628.6046.71
Price / Book32.484.6711.096.19
Net Income$11.60M-$25.90M$3.49B$347.61M
7 Day Performance-5.31%0.92%0.42%0.74%
1 Month Performance-10.09%-3.32%-4.33%-3.72%
1 Year Performance60.10%-18.87%63.09%20.27%

National Research Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NRC
National Research
2.8247 of 5 stars
$20.14
+3.2%
$26.00
+29.1%
+55.1%$458.06M$140.00M80.55490
STGW
Stagwell
3.6621 of 5 stars
$7.97
+3.1%
$7.80
-2.1%
+51.4%$1.92B$2.91B113.8612,629
EVTC
Evertec
3.9838 of 5 stars
$31.58
+3.6%
$32.75
+3.7%
-12.2%$1.88B$931.82M15.265,327
PRG
PROG
3.9984 of 5 stars
$45.07
+4.1%
$47.36
+5.1%
+43.9%$1.73B$2.41B12.311,151
NEO
NeoGenomics
2.0327 of 5 stars
$13.40
+2.0%
$14.57
+8.7%
+196.3%$1.71B$745.97MN/A2,500

Related Companies and Tools


This page (NASDAQ:NRC) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners